A clinical study on the treatment of androgenetic alopecia and senile alopecia with CGF, and the differential gene expression

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037274

Enrollment

Unknown

Registered

2020-08-27

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

androgenetic alopecia and senile alopecia

Interventions

experimental group:GCF infection

Eligibility

Sex/Gender

All

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Androgenic alopecia (Hamilton II, III, IV), the proportion of fine hair in the parietal and frontal area under the hair microscope assessment is more than 20% admitted. Access to aging alopecia: the proportion of fine occipital hair > 10%. 2. Aged 20 to 45 years, no serious heart and lung diseases, no active infectious diseases, blood system diseases, tumors, autoimmune diseases; 3. Sign the informed consent and be willing to accept surgical treatment; 4. Those who have not used finasteride or minoxidil.

Exclusion criteria

Exclusion criteria: 1. Patients with scars; 2. Patients who cannot cooperate with treatment; 3. Patients who have serious medical or infectious diseases and are not suitable for traumatic operations. 4. Female pregnancy 5. Participate in other clinical studies recently

Design outcomes

Primary

Measure	Time frame
diameter;Hair density;Hair color;single-hair follicles proportion;SALT;	—

Secondary

Measure	Time frame
moisture content;Sebum content;scurf content;	—

Countries

China

Contacts

Public ContactYuchong Chen

Shanghai Dermatology Hospital

973309637@qq.com+86 13681706567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026